HomeKROS • NASDAQ
add
Keros Therapeutics Inc
Previous close
$10.92
Day range
$10.62 - $11.47
Year range
$9.78 - $72.37
Market cap
464.21M USD
Avg Volume
1.07M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Revenue | 3.04M | 2,027.27% |
Operating expense | 166.00M | 27.42% |
Net income | -46.03M | -14.37% |
Net profit margin | -1.51K | 94.62% |
Earnings per share | -1.14 | 14.93% |
EBITDA | -52.92M | -14.53% |
Effective tax rate | -0.66% | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Cash and short-term investments | 559.93M | 69.09% |
Total assets | 615.89M | 66.44% |
Total liabilities | 44.33M | 17.25% |
Total equity | 571.55M | — |
Shares outstanding | 40.56M | — |
Price to book | 0.77 | — |
Return on assets | -22.28% | — |
Return on capital | -23.30% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2024info | Y/Y change |
|---|---|---|
Net income | -46.03M | -14.37% |
Cash from operations | -46.01M | -80.71% |
Cash from investing | -289.00K | 46.58% |
Cash from financing | 75.54M | 9.08% |
Net change in cash | 29.25M | -32.38% |
Free cash flow | -33.32M | -132.50% |
About
Founded
2015
Headquarters
Website
Employees
169
